is a director of the Life Sciences practice at Lloreda Camacho & Co. He specialises in administrative law. His experience includes work as legal counsel to national and international companies on health/sanitary legislation with an emphasis on the pharmaceutical and food sectors. He also advises on biotechnology, access to new drugs, requirements by the Special Panel of the INVIMA Review Commission, clinical studies, patient programmes, access programmes, and risk-sharing plans. In addition, Daniel provides legal advice and defence to companies in administrative procedures initiated by INVIMA, FNE, health secretaries and the Superintendence of Industry and Commerce (SIC).
Chambers and Partners make no representation or endorsement of the quality and services supplied
by companies or firms that may be found on this website. In no event will Chambers and Partners
be liable for any damages including, without limitation, indirect or consequential damages,
or any damages whatsoever arising from use or loss of use, data, or profits, whether in action
of contract, negligence or other tort action, arising out of or in connection with the use
of the website.